Breaking News

Pakistan rejects India’s ‘malicious’ statement linking UN-designated individual with FATF

Islamabad, January 09, 2021 (PPI-OT): Pakistan has categorically rejected malicious statement by Indian Ministry of External Affairs regarding conviction of an UN-designated individual by an Anti-Terrorism Court in Pakistan. In a statement on Saturday, the foreign office spokesperson Zahid Hafeez Chaudhri said that India has no locus standi to comment on the independent judicial mechanisms of Pakistan. In this regard the only ‘compliance’ that interests Pakistan is abiding by its own statutes and fulfilment of its international obligations.

The spokesperson said the investigations, prosecutions and subsequent convictions, through due process, are a reflection of the effectiveness of Pakistan’s legal system, which operates independent of any extraneous factors or influences.

He said India’s assertions to link Pakistan’s due legal process with FATF are unfortunate. It is yet another Indian attempt to politicize FATF and use its processes against Pakistan. Pakistan reiterates its commitment to impartiality, confidentiality and technical nature of the FATF process.

He said Indian insinuations against Pakistan are in fact a vain attempt to conceal its failures to bring to justice those blatantly involved in state terrorism and brutal suppression against the subjugated people of IIOJK and other minority communities.

For more information, contact:
Ministry of Information and Broadcasting
Government of Pakistan
4th Floor, Cabinet Block, Pak. Secretariat, Islamabad, Pakistan
Tel: +92-51-9103557
Email: info@moib.gov.pk
Website: http://www.moib.gov.pk

Check Also

EAACI Congress 2024: Innovation and Advances in Allergy Treatment

EAACI Congress 2024 Over 150 scientific sessions will be presented during the congress, focusing on advancements in environmental science, food allergies, innovations in immunotherapy, and pediatric allergies, among others. Precision medicine, AI, immunotherapy, and immune modulators will converge at the largest allergy and immunology congress. The congress will occur from 31 May to 3 June […]